Found: 14
Select item for more details and to access through your institution.
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 4, p. 690, doi. 10.1111/bjh.17527
- By:
- Publication type:
- Article
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 987, doi. 10.1007/s00277-021-04419-w
- By:
- Publication type:
- Article
Age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorders in elderly White patients.
- Published in:
- 2010
- By:
- Publication type:
- Letter
ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01890-5
- By:
- Publication type:
- Article
Poster: ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S238, doi. 10.1016/S2152-2650(21)01496-8
- By:
- Publication type:
- Article
Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E52, doi. 10.1002/ajh.24981
- By:
- Publication type:
- Article
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E105, doi. 10.1002/ajh.24715
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 366, doi. 10.1002/ajh.24278
- By:
- Publication type:
- Article
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 6, p. 2905, doi. 10.62347/LLXR8002
- By:
- Publication type:
- Article
Early Versus Late Intensification for Patients With High-Risk Hodgkin Lymphoma-3 Cycles of Intensive Chemotherapy Plus Low-Dose Lymph Node Radiation Therapy Versus 4 Cycles of Combined Doxorubicin, Bleomycin, Vinbiastine, and Dacarbazine Plus Myeloablative Chemotherapy With Autologous Stem Cell Transplantation
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 12, p. 3323, doi. 10.1002/cncr.23979
- By:
- Publication type:
- Article
Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 2, p. 202, doi. 10.1111/j.1365-2141.2007.06647.x
- By:
- Publication type:
- Article
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51264-2
- By:
- Publication type:
- Article
Suppressive properties of human CD4.
- Published in:
- European Journal of Immunology, 2004, v. 34, n. 12, p. 3485, doi. 10.1002/eji.200324632
- By:
- Publication type:
- Article